Patents by Inventor Fabrizio Arigoni
Fabrizio Arigoni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230098927Abstract: The present invention relates generally to the field of compositions for use in diagnostic methods. In particular, the present invention relates to a composition for use in a diagnostic method wherein the composition is a nutritional composition comprising 15-70 g fat, 60-90 g carbohydrates and 15-35 g protein. The diagnostic method may be a method to predict the risk of atheroma plaque presence in a subject.Type: ApplicationFiled: March 29, 2021Publication date: March 30, 2023Inventors: LUCAS ACTIS GORETTA, ARMAND VALSESIA, LEONIE EGLI, FABRIZIO ARIGONI, DIANE ZIMMERMANN, NASHMIL EMAMI, MOHAMED NABIL BOSCO, KHEE SHING MELVIN LEOW, KHUNG KEONG YEO
-
Publication number: 20160051814Abstract: The present invention generally relates to the filed of medical nutrition. For example, the present invention relates to a composition comprising an amino acid source that in combination with electrical muscle stimulation can be used for the treatment of prevention of sarcopenia, for for reducing the loss of muscle morphology, for increasing the muscle morphology, and/or for improving muscle recovery after muscle atrophy in elderly humans.Type: ApplicationFiled: April 14, 2014Publication date: February 25, 2016Inventors: Fabrizio Arigoni, Denis Breuille, Toshio Mortani, Elizabeth Offord Cavin, Gerard Vinyes Pares
-
Patent number: 9101651Abstract: The present invention generally relates to the field of obesity. In particular the present invention relates to the use of probiotics to treat obesity. One embodiment of the present invention relates to the use of Lactobacillus rhamnosus CGMCC 1.3724 and/or Lactobacillus rhamnosus NCC 4007 for the preparation of a composition to support weight management, promote weight loss and/or to treat obesity.Type: GrantFiled: April 10, 2013Date of Patent: August 11, 2015Assignee: Nestec S.A.Inventors: Christian Darimont, David Philippe, Catherine Mace, Fabrizio Arigoni
-
Publication number: 20140227789Abstract: The present invention relates in general to the field of Bifidobacteria. In particular, the present invention relates to the field of Bifidobacteria with a modulated stress resistance. One embodiment of the present invention is a Bifidobacterium with a constitutively modulated DnaK, GrpE and/or CIpB expression.Type: ApplicationFiled: April 22, 2014Publication date: August 14, 2014Applicant: NESTEC S.A.Inventors: Bernard Berger, Ernea Rezzonico, Fabrizio Arigoni
-
Patent number: 8741622Abstract: The present invention relates in general to the field of Bifidobacteria. In particular, the present invention relates to the field of Bifidobacteria with a modulated stress resistance. One embodiment of the present invention is a Bifidobacterium with a constitutively modulated DnaK, GrpE and/or CIpB expression.Type: GrantFiled: March 20, 2013Date of Patent: June 3, 2014Assignee: Nestec S.A.Inventors: Bernard Berger, Enea Rezzonico, Fabrizio Arigoni
-
Patent number: 8591880Abstract: The present invention relates to supporting weight management, weight loss and/or to the prevention and/or treatment of metabolic disorders. In particular the present invention relates to preventing and/or treating metabolic disorders by modulating, in particular reducing the amount of proteobacteria and/or deferribacteres in the gut. One embodiment of the present invention relates to the use of a primary composition comprising an agent that reduces the amount of proteobacteria, preferably gamma-proteobacteria, even more preferred enterobacteria; and/or deferribacteres in the gut for the preparation of a composition to treat or prevent metabolic disorders, to support weight loss and/or to support weight management.Type: GrantFiled: July 25, 2008Date of Patent: November 26, 2013Assignee: Nestec S.A.Inventors: Chieh Jason Chou, David Philippe, Christian Darlmont, Fabrizio Arigoni, Catherine Mace
-
Publication number: 20130273660Abstract: The present invention relates in general to the field of Bifidobacteria. In particular, the present invention relates to the field of Bifidobacteria with a modulated stress resistance. One embodiment of the present invention is a Bifidobacterium with a constitutively modulated DnaK, GrpE and/or CIpB expression.Type: ApplicationFiled: March 20, 2013Publication date: October 17, 2013Inventors: Bernard Berger, Enea Rezzonico, Fabrizio Arigoni
-
Patent number: 8454949Abstract: The present invention generally relates to the field of obesity. In particular the present invention relates to the use of probiotics to support weight management and to treat or prevent obesity. One embodiment of the present invention relates to the use of Lactobacillus helveticus CNCM I-4095 for the preparation of a composition to support weight management, promote weight loss and/or to treat obesity.Type: GrantFiled: February 4, 2010Date of Patent: June 4, 2013Assignee: Nestec S.A.Inventors: Fabrizio Arigoni, Christian Darimont-Nicolau, Catherine Mace
-
Patent number: 8440178Abstract: The present invention generally relates to the field of obesity. In particular the present invention relates to the use of probiotics to treat obesity. One embedment of the present invention relates to the use of Lactobacillus rhamnosus CGMCC 1.3724 and/or Lactobacillus rhamnosus NCC 4007 for the preparation of a composition to support weight management, promote weight loss and/or to treat obesity.Type: GrantFiled: July 24, 2008Date of Patent: May 14, 2013Assignee: Nestec S.A.Inventors: Christian Darimont, David Philippe, Catherine Mace, Fabrizio Arigoni
-
Patent number: 8426190Abstract: The present invention relates in general to the field of Bifidobacteria. In particular the present invention relates to the field of Bifidobacteria with a modulated stress resistance. One embodiment of the present invention is a Bifidobacterium with a constitutively modulated DnaK, DnaJ, GrpE and/or CIpB expression.Type: GrantFiled: October 22, 2008Date of Patent: April 23, 2013Assignee: Nestec S.A.Inventors: Bernard Berger, Enea Rezzonico, Fabrizio Arigoni
-
Patent number: 8318151Abstract: The present invention generally relates to the field of weight management and obesity. In particular the present invention relates to the use of probiotics in combination with prebiotics to treat or prevent obesity. One embodiment of the present invention relates to the use of Lactobacillus rhamnosus NCC 4007 in combination with a specific probiotic mixture for the preparation of a composition to support weight management, promote weight loss and/or to treat obesity.Type: GrantFiled: February 4, 2010Date of Patent: November 27, 2012Assignee: Nestec S.A.Inventors: Christian Darimont-Nicolau, David Philippe, Catherine Mace, Fabrizio Arigoni
-
Patent number: 8318150Abstract: The present invention generally relates to the field of obesity. In particular the present invention relates to the use of probiotics to support weight management and to treat or prevent obesity. One embodiment of the present invention relates to the use of Lactobacillus rhamnosus CNCM I-4096 for the preparation of a composition to support weight management, promote weight loss and/or to treat obesity.Type: GrantFiled: February 4, 2010Date of Patent: November 27, 2012Assignee: Nestec S.A.Inventors: Fabrizio Arigoni, Christian Darimont-Nicolau, Catherine Mace
-
Publication number: 20120135460Abstract: The present invention generally relates to the field of proteinases and more specifically to chymotrypsin. In particular, the present invention relates to recombinant porcine chymotrypsin and its use in food applications.Type: ApplicationFiled: December 11, 2009Publication date: May 31, 2012Applicant: NESTEC S.A.Inventors: Raymond-David Pridmore, Fabrizio Arigoni, Francoise Maynard, Isabelle Bureau-Franz
-
Publication number: 20120114622Abstract: The present invention generally relates to the field of obesity. In particular the present invention relates to the use of probiotics to treat obesity. One embedment of the present invention relates to the use of Lactobacillus rhamnosus CGMCC 1.3724 and/or Lactobacillus rhamnosus NCC 4007 for the preparation of a composition to support weight management, promote weight loss and/or to treat obesity.Type: ApplicationFiled: July 24, 2008Publication date: May 10, 2012Applicant: NESTEC S.A.Inventors: Christian Darimont, David Philippe, Catherine Mace, Fabrizio Arigoni
-
Publication number: 20120107279Abstract: This invention relates to Bifidobacterium breve CNCM I-3865, to a composition comprising Bifidobacterium breve CNCM I-3865 and to the use of Bifidobacterium breve CNCM I-3865 in the prevention or treatment of rotavirus diarrhoea.Type: ApplicationFiled: November 27, 2009Publication date: May 3, 2012Applicant: NESTEC S.A.Inventors: Fabrizio Arigoni, Harald Bruessow, Christoph Cavadini, Nicolas Page
-
Publication number: 20120039852Abstract: The present invention generally relates to the field of weight management and obesity. In particular the present invention relates to the use of probiotics in combination with prebiotics to treat or prevent obesity. One embodiment of the present invention relates to the use of Lactobacillus rhamnosus NCC 4007 in combination with a specific probiotic mixture for the preparation of a composition to support weight management, promote weight loss and/or to treat obesity.Type: ApplicationFiled: February 4, 2010Publication date: February 16, 2012Applicant: NESTEC S.A.Inventors: Christian Darimont-Nicolau, David Philippe, Catherine Mace, Fabrizio Arigoni
-
Publication number: 20120016112Abstract: The present invention generally relates to edible compositions and methods to produce them. In particular, the present invention relates to the enzymatic modulation of macron utrients and to food compositions containing such modulated macronutrients. One embodiment of the present invention is a method for modulating macronutrients comprising the steps of producing at least one synthetic gene coding for at least one enzyme or a functional part thereof capable of modulating macronutrients, expressing the at least one enzyme or a functional part thereof, and bringing the macronutrients into contact with the at least one enzyme or a functional part thereof exhibiting the enzymatic activity.Type: ApplicationFiled: December 11, 2009Publication date: January 19, 2012Applicant: Nestec S.A.Inventors: Raymond-David Pridmore, Fabrizio Arigoni, Francoise Maynard, Isabelle Bureau-Franz
-
Patent number: 8071353Abstract: A Bifidobacterium comprising a genome that is customized so as to lack an operable functional gene is disclosed. A method of making such cells is also disclosed. The method is used to make Bifidobacterium cells that lack certain functional antibiotic resistance genes, such as tetW, and are sensitive to antibiotics such as tetracycline.Type: GrantFiled: August 17, 2007Date of Patent: December 6, 2011Assignee: Nestec S.A.Inventors: Fabrizio Arigoni, Michele Delley
-
Publication number: 20110293569Abstract: The present invention generally relates to the field of obesity. In particular the present invention relates to the use of probiotics to support weight management and to treat or prevent obesity. One embodiment of the present invention relates to the use of Lactobacillus rhamnosus CNCM I-4096 for the preparation of a composition to support weight management, promote weight loss and/or to treat obesity.Type: ApplicationFiled: February 4, 2010Publication date: December 1, 2011Applicant: NESTEC S.A.Inventors: Fabrizio Arigoni, Christian Darimont-Nicolau, Catherine Mace
-
Publication number: 20110293568Abstract: The present invention generally relates to the field of obesity. In particular the present invention relates to the use of probiotics to support weight management and to treat or prevent obesity. One embodiment of the present invention relates to the use of Lactobacillus helveticus CNCM I-4095 for the preparation of a composition to support weight management, promote weight loss and/or to treat obesity.Type: ApplicationFiled: February 4, 2010Publication date: December 1, 2011Applicant: NESTEC S.A.Inventors: Fabrizio Arigoni, Christian Darimont-Nicolau, Catherine Mace